Disease awareness talk: Ankylosing Spondylitis

Speciality: Rheumatology


Speaker:

Dr. Shriram Garg | Dermatologist

Description:

A warm welcome to all the medical professionals in this interesting session on Disease awareness talk: Ankylosing Spondylitis.
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints, leading to pain, stiffness, and eventual fusion of the vertebrae in severe cases. Early symptoms often include persistent lower back pain and stiffness, especially in the morning or after periods of inactivity. AS can also affect other areas of the body, such as the hips, shoulders, and even organs like the eyes (causing uveitis). Early detection is crucial in slowing the progression of the disease and preventing long-term disability.
During a disease awareness talk, it’s important to emphasize that AS typically begins in young adulthood and often goes undiagnosed for years due to its gradual onset. Effective management includes a combination of medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), biologics like TNF inhibitors, and physical therapy to maintain flexibility and mobility. Raising awareness about AS can help individuals recognize early symptoms, seek timely medical intervention, and improve their quality of life through appropriate treatment and lifestyle modifications.
Therefore, get an overall knowledge of Disease awareness talk: Ankylosing Spondylitis. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
 

See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot